A Multisite Randomized Controlled Trial of Mindfulness Meditation Therapy for PTSD
The trial, sponsored by the US Department of Veterans Affairs, addresses a significant unmet medical need for effective PTSD treatments among veterans, particularly in light of the limited efficacy of current pharmacological options. The study compares MBSR to Present Centered Group Therapy (PCGT), positioning MBSR as a potential complementary therapy in the mental health market. The findings could influence treatment guidelines and expand the market for non-pharmacological interventions in PTSD, potentially leading to partnerships with healthcare providers and mental health organizations. The trial's completion and results could enhance the credibility of MBSR, paving the way for broader adoption in clinical settings and potential reimbursement pathways.
Indication: Posttraumatic Stress Disorder
Modality: behavioral intervention
Target: Mindfulness Based Stress Reduction (MBSR) as a therapeutic intervention for PTSD symptoms.
Sponsor: US Department of Veterans Affairs
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 17, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Mindfulness Based Stress Reduction (MBSR) as a therapeutic intervention for PTSD symptoms.
View original source fields
Condition raw: Posttraumatic Stress Disorder
Condition normalized: Posttraumatic Stress Disorder
Modality raw: behavioral intervention
Modality normalized: behavioral intervention
Target raw: Mindfulness Based Stress Reduction (MBSR) as a therapeutic intervention for PTSD symptoms.
Target normalized: Mindfulness Based Stress Reduction (MBSR) as a therapeutic intervention for PTSD symptoms.